Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2026-02-25 @ 10:05 PM
Study NCT ID:
NCT00565851
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-12-10
First Post:
2007-11-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Clear Cell Adenocarcinoma | View |
| None | Fallopian Tube Clear Cell Adenocarcinoma | View |
| None | Fallopian Tube Endometrioid Adenocarcinoma | View |
| None | Fallopian Tube Mucinous Adenocarcinoma | View |
| None | Fallopian Tube Serous Adenocarcinoma | View |
| None | Fallopian Tube Transitional Cell Carcinoma | View |
| None | Fallopian Tube Undifferentiated Carcinoma | View |
| None | Mucinous Adenocarcinoma | View |
| None | Ovarian Brenner Tumor | View |
| None | Ovarian Clear Cell Adenocarcinofibroma | View |
| None | Ovarian Clear Cell Adenocarcinoma | View |
| None | Ovarian Endometrioid Adenocarcinoma | View |
| None | Ovarian Seromucinous Carcinoma | View |
| None | Ovarian Serous Adenocarcinoma | View |
| None | Ovarian Transitional Cell Carcinoma | View |
| None | Ovarian Undifferentiated Carcinoma | View |
| None | Primary Peritoneal Clear Cell Adenocarcinoma | View |
| None | Primary Peritoneal Endometrioid Adenocarcinoma | View |
| None | Primary Peritoneal Serous Adenocarcinoma | View |
| None | Primary Peritoneal Transitional Cell Carcinoma | View |
| None | Primary Peritoneal Undifferentiated Carcinoma | View |
| None | Recurrent Fallopian Tube Carcinoma | View |
| None | Recurrent Ovarian Carcinoma | View |
| None | Recurrent Primary Peritoneal Carcinoma | View |
| None | Undifferentiated Carcinoma | View |
Keywords: